These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6413305

  • 1. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D, Eckstein N, Avidan S, Eshel A, L'Hermite M, Caufriez A, Spitz I, Zylber-Haran E.
    Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Perić LA.
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [Abstract] [Full Text] [Related]

  • 3. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S, Spitz IM, Ben-David M, Polishuk WZ.
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [Abstract] [Full Text] [Related]

  • 4. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG, Prescott RW, Kendall-Taylor P, Hall K, Crombie AL, Hall R, McGregor A, Watson MJ, Cook DB.
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [Abstract] [Full Text] [Related]

  • 6. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW, Docter R, De Jong FH, Birkenhäger JC, Kwa HG.
    Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383
    [Abstract] [Full Text] [Related]

  • 7. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K, Smid I, Kunkel S, Bazsa-Kassai Z.
    Zentralbl Gynakol; 1985 Mar; 107(14):894-8. PubMed ID: 3929499
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis of prolactin-secreting pituitary microadenoma.
    Wiebe RH, Hammond CB, Borchert LG.
    Am J Obstet Gynecol; 1976 Dec 15; 126(8):993-6. PubMed ID: 1033671
    [Abstract] [Full Text] [Related]

  • 9. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I, Ambrosi F, Giammartino C, Fedeli L, Mannarelli C, Filipponi P.
    Horm Metab Res; 1986 Jul 15; 18(7):479-84. PubMed ID: 3091473
    [Abstract] [Full Text] [Related]

  • 10. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
    Le Roith D, Potashnik G, Glick SM.
    Int J Fertil; 1979 Jul 15; 24(2):145-7. PubMed ID: 40911
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
    Ayalon D, Persitz E, Ravid R, Jedwab G, Avidan S, Cordova T, Harell A.
    Clin Endocrinol (Oxf); 1979 Jul 15; 11(2):201-15. PubMed ID: 114343
    [Abstract] [Full Text] [Related]

  • 12. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A, Finkel DM, Schatz NJ, Savino PJ, Snyder PJ.
    Ann Intern Med; 1984 Dec 15; 101(6):783-5. PubMed ID: 6497193
    [Abstract] [Full Text] [Related]

  • 13. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1984 Nov 15; 59(5):941-8. PubMed ID: 6434588
    [Abstract] [Full Text] [Related]

  • 14. Lowering prolactin level in a hyperprolactinemic man: responses of luteinizing hormone, follicle-stimulating hormone, and testosterone.
    Davis JL.
    Arch Intern Med; 1982 Jan 15; 142(1):146-8. PubMed ID: 6797361
    [Abstract] [Full Text] [Related]

  • 15. Prolactin: Physiology and pathology.
    Tolis G.
    Hosp Pract; 1980 Feb 15; 15(2):85-95. PubMed ID: 6773874
    [Abstract] [Full Text] [Related]

  • 16. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M, Olchovsky D, Pines A, Tadmor R, Lunenfeld B.
    J Clin Endocrinol Metab; 1984 Dec 15; 59(6):1220-3. PubMed ID: 6436289
    [Abstract] [Full Text] [Related]

  • 17. Prolactin-secreting pituitary microadenoma: detection and evaluation.
    Wiebe RH, Hammond CB, Handwerger S.
    Fertil Steril; 1978 Mar 15; 29(3):282-6. PubMed ID: 640047
    [Abstract] [Full Text] [Related]

  • 18. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.
    van Roon E, van der Vijver JC, Gerretsen G, Hekster RE, Wattendorff RA.
    Fertil Steril; 1981 Aug 15; 36(2):173-7. PubMed ID: 6790306
    [Abstract] [Full Text] [Related]

  • 19. [Gonadotropic pituitary adenoma and pregnancy. Value of bromocriptine].
    Robert M, Leriche-Polverelli A, Hamon P, Labat-Moleur F, Tourniaire J.
    Presse Med; 1991 Mar 23; 20(11):503-6. PubMed ID: 1827188
    [Abstract] [Full Text] [Related]

  • 20. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
    Maxson WS, Dudzinski M, Handwerger SH, Hammond CB.
    Fertil Steril; 1984 Feb 23; 41(2):218-23. PubMed ID: 6698215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.